Biopharma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Biopharma
May 29, 2024, 12:59 |
Blog
How can we bring greater precision to oncology omnichannel experiences? - Inizio
Inizio shared a post on LinkedIn: "How can we bring greater precision to oncology omnichannel…
Apr 28, 2024, 23:46 |
Blog
Belén Garijo: The ARC is one of over a dozen major Merck projects, we call it the Merck Innovation Mile
Belén Garijo shared a post on LinkedIn: “We at Merck Group are a global company…
Apr 24, 2024, 22:11 |
Blog
Najat Khan: It's bittersweet to announce my resignation from my role as the Chief Data Science Officer and Global Head, Strategy and Portfolio Organization of Johnson and Johnson
Mar 7, 2024, 05:23 |
Blog
William Coyle: WHO's recent global report on cancer underscores the disease’s fascinating and frightening dynamic
William Coyle, Region Managing Principal- East Asia at ZS Associates, shared a post on LinkedIn:…
Jan 16, 2024, 07:31 |
Blog
22 Tweets from JPM 2024 not to miss
The 42nd J.P. Morgan Annual Healthcare Conference took place from January 8th to January 11th,…
Dec 10, 2023, 18:07 |
Blog
Nathan Vardi: I traveled down to Maryland and spent the day at the FDA
Nathan Vardi, Managing Editor, Enterprise at MarketWatch, shared on LinkedIn: "Not long after my book, FOR…
Dec 3, 2023, 15:29 |
Insight
Leon 'Jun' Tang: Cross-border Business Development and partnerships will be essential for China Biotech to survive and thrive
Leon 'Jun' Tang, Founding Partner and Entrepreneur of Biotech BD and VC, shared a post…
All:
7
Posts:
1 - 100
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Facebook
RSS Feed
Twitter
Linkedin
Youtube